Abiopharma

🔍 WINTER JOHN M (Executive)

Company: Liberty Latin America Ltd. (LILA)

Report Date: 2026-06-26

Detailed Transactions and Holdings:

• Acquired 59,476 shares of Series A Preference Shares (Direct)
  Date: 2026-06-16 | Code: J | equity_swap_involved: 0 | shares_owned_after: 59,476.00 | transaction_form_type: 5 | Footnotes: F1
• Acquired 5,071 shares of Series A Preference Shares at $19.6684 per share (Direct)
  Date: 2026-06-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 64,547.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 59,476 Preferred Shares.
• F2: The price reflects a weighted average of purchases made at prices ranging from $19.5600 to $19.7700. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price.
• REMARKS: The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK, and the trading symbol for the Issuer's Series A Preference Shares is LILAP.